Honigsbaum M. Disease X and other unknowns[J]. The Lancet, 2019,393(10180):1496-1497.
[7]
Xia S,Yan L,Xu W,et al.A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike[J].Sci Found China, 2019,27(2):22.
[8]
Jonkmans N, D'Acremont V, Flahault A. Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases[J].BMJ Glob Health, 2021,6(9).
[9]
Salmanton-García J, Wipfler P, Leckler J, et al. Predicting the next pandemic: vaccelerate ranking of the World Health Organization's blueprint for action to prevent epidemics[J]. Travel Med Infect Dis, 2024,57:102676.
[10]
Roknuzzaman A S M,Aminul H M,Sabrina S,et al.The mysterious “Disease X” - a correspondence evaluating its public health threat, the global preparedness, and possible ways to avoid next pandemic[J].Int J Surg, 2023,60(11):100703.
[11]
Gostin L.Living in an age of pandemics-from COVID-19 to monkeypox, polio, and disease X[J]. JAMA Health Forum, 2022,3(9):e224062.
[12]
Islam A,Ferdous J,Islam S,et al.Transmission dynamics and susceptibility patterns of SARS-CoV-2 in domestic, farmed and wild animals: sustainable one health surveillance for conservation and public health to prevent future epidemics and pandemics[J].Transbound Emerg Dis,2022,69(5):2523-2543.
[13]
Berezowski J,Balogh K,Dórea F C,et al.Prioritisation of zoonotic diseases for coordinated surveillance systems under the one health approach for cross-border pathogens that threaten the union[J].EFSA J, 2023,21(3):e07853.
[14]
Gail H, Jonna M, Jonathan R, et al.What happens after Disease X: using one health to prevent the next pandemic[J].Nam Perspect,2020,2020(9).
[15]
Manirambona E,Okesanya O J,Shomuyiwa D O,et al.Mitigating the threat of “Disease X” to global health security[J].New Microb New Infect,2024,57:101223.
[16]
Chatterjee P, Nair P, Chersich M, et al.One Health, "Disease X" & the challenge of "Unknown" Unknowns[J]. Indian J Med Res,2021,153(3):264-271.
Ishrat M,Vinay G N,Arun S M, et al. Disease X: combating the next pandemic needs the nifty wastewater-based epidemiology tool[J]. Inter J Surg,2023,60:100701.
[22]
Zaman M H,Ali N,Ilyas M.“Disease X” and prevention policies[J]. Front Public Heal, 2024,12:1303584.
[23]
Van Kerkhove M D, Ryan M J, Ghebreyesus T A. Preparing for "Disease X"[J]. Science, 2021,374(6566):377.
[24]
Christofferson R C, Cormier S A.Beyond the unknown: a broad framing for preparedness for emerging infectious threats[J]. Am J Trop Med Hyg, 2022,107(6):1159-1161.
[25]
M S L, Vikramjit M. Special pathogens readiness in the United States: from ebola to Covid-19 to Disease X and beyond[J].Health Security, 2022,20(S1).
[26]
Daniele M,Chiara M,Barbara B,et al. 'Disease X'-time to act now and prepare for the next pandemic threat[J]. Eur J Public Health,2022,32(6).
[27]
Junaid T M, Imaduddin S, Yasir E M, et al.Disease X: a hidden but inevitable creeping danger[J].Infect Cont Hosp Ep, 2021,43(11):1-5.
[28]
Tian Q, Han Z, Xue L L,et al. Disease X testing: the results of an international external quality assessment exercise[J]. J Biosafe Biosecur,2022,4(2):151-157.
[29]
Simpson S,Kaufmann M C,Glozman V,et al.Disease X:accelerating the development of medical countermeasures for the next pandemic[J].Lancet Infect Dis,2020,20(5):e108-e115.
[30]
Radanliev P,De Roure D,Maple C,et al. Methodology for integrating artificial intelligence in healthcare systems: learning from Covid-19 to prepare for Disease X[J].AI Ethics, 2022,2(4):623-630.
[31]
Possas C, Marques E, Risi J J, et al. Covid-19 and future Disease X in circular economy transition: redesigning pandemic preparedness to prevent a global disaster[J].Circ Econ Sustain, 2021,1(4):1463-1478.
[32]
Su Z, McDonnell D, Bentley B L, et al.Addressing biodisaster X threats with artificial intelligence and 6G technologies: literature review and critical insights[J].J Med Internet Res,2021,23(5):e26109.
[33]
Nielsen B F,Sneppen K,Simonsen L.The counterintuitive implications of superspreading diseases[J].Nat Commun,2023,14(1):6954.
[34]
Armitage R,Nellums L B. Disease X: availability bias, biotechnology and seeing beyond zoonotic risk[J]. Public Health, 2020,190.
2024, Vol. 35 
